Amino acid analysis in advanced tumors can guide the application of novel therapies, such as PHGDH inhibitors for serine-dependent cancers or targeting asparagine metabolism to reduce metastatic spread (Knott et al., 2018). The gene discussed is PHGDH; the disease is cancer.